 "Ramdev has no ill-will against modern science, its practitioners: Patanjali")
Patanjali Yogpeeth Trust on Saturday denied allegations by the Indian Medical Association (IMA) that yoga guru Ramdev has misled people by making "unlearned" statements against allopathy and defamed scientific medicine.
Citing a video circulating on social media, the IMA had earlier on Saturday said Ramdev is seen saying that "allopathy ek aisi stupid aur diwalilya science hai... (allopathy is such a stupid science)"
Ramdev has "utmost regards" for doctors and support staff who have been working day and night during such a challenging time of the pandemic, said a statement issued by the Haridwar-based Patanjali Yogpeeth Trust.
He was "reading out a forwarded WhatsApp message received by him and various other members who were participating in the event", it added.
"Swami jee has no ill-will against the modern science and good practitioners of modern medicine. What is being attributed against him is false and nugatory," said the statement signed by Patanjali Yogpeeth Trust General Secretary Acharya Balakrishna.
Earlier, the IMA said the Union health ministry should take action against Ramdev as he has misled people by making "unlearned" statements against allopathy and defamed scientific medicine.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app